1Karin, M (2006) Nuclear factor-kB in cancer development and progression. Nature 441, 431–436.
2Rollins, BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42, 760–767.
3Hong, MY, Lupton, JR, Morris, JS, Wang, N, Carroll, RJ, Davidson, LA, Elder, RH & Chapkin, RS (2000) Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol Biomarkers Prev 9, 819–826.
4Chapkin, RS, McMurray, DN & Lupton, JR (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23, 48–54.
5Fowler, KH, Chapkin, RS & McMurray, DN (1993) Effects of purified dietary n-3 ethyl esters on murine T-lymphocyte function. J Immunol 151, 5186–5197.
6Serhan, CN, Yacoubian, S & Yang, R (2008) Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol Mech Dis 3, 279–312.
7Ariel, A & Serhan, CN (2007) Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28, 176–183.
8Bazan, NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10, 136–141.
9deUrquiza, AM, Liu, S, Sjoberg, M, Zetterström, RH, Griffiths, W, Sjövall, J & Perlmann, T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290, 2140–2144.
10Fan, YY, Spencer, TE, Wang, N, Moyer, MP & Chapkin, RS (2003) Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis 4, 1541–1548.
11Davidson, LA, Nguyen, DV, Hokanson, RM, et al. (2004) Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 64, 6797–6804.
12Jump, DB, Botolin, D, Wang, Y, Xu, J, Christian, B & Demeure, O (2005) Fatty acid regulation of hepatic gene transcription. J Nutr 135, 2503–2506.
13Ma, DW, Seo, J, Switzer, KC, Fan, YY, McMurray, DN, Lupton, JR & Chapkin, RS (2004) n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 15, 700–706.
14Seo, J, Barhoumi, R, Johnson, AE, Lupton, JR & Chapkin, RS (2006) Docosahexaenoic acid selectively inhibits plasma membrane targeting of lipidated proteins. FASEB J 20, 770–772.
15Kolar, SS, Barhoumi, R, Lupton, JR & Chapkin, RS (2007) Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation. Cancer Res 67, 5561–5568.
16Kolar, SS, Barhoumi, R, Callaway, ES, Fan, YY, Wang, N, Lupton, JR & Chapkin, RS (2007) Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes. Am J Physiol Gastrointest Liver Physiol 293, G935–G943.
17Chapkin, RS, Wang, N, Fan, YY, Lupton, JR & Prior, IA (2008) Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta 1778, 466–471.
18Biscione, F, Pignalberi, C, Totteri, A, Messina, F & Altamura, G (2007) Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol 5, 163–172.
19Harris, WS, Poston, WC & Haddock, CK (2007) Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193, 1–10.
20Ou, L, Ip, C, Lisafeld, B & Ip, MM (2007) Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss. Biochem Biophys Res Commun 356, 1044–1049.
21Bozzo, F, Bocca, C, Colombatto, S & Miglietta, A (2007) Antiproliferative effect of conjugated linoleic acid in Caco-2 cells: involvement of PPARγ and APC/β-catenin pathways. Chem Biol Interact 169, 110–121.
22Song, HJ, Sneddon, AA, Heys, SD & Wahle, KW (2006) Induction of apoptosis and inhibition of NF-κB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 66, 839–846.
23Chung, S, Brown, JM, Provo, JN, Hopkins, R & McIntosh, MK (2005) Conjugated linoleic acid promotes human adipocyte insulin resistance through NF-κB dependent cytokine production. J Biol Chem 280, 38445–38456.
24Liu, LF, Purushotham, A, Wendel, AA & Belury, MA (2007) Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Am J Physiol Liver Physiol 292, G1671–G1682.
25Pérez-Matute, P, Marti, A, Martínez, JA, Fernández-Otero, MP, Stanhope, KL, Havel, PJ & Moreno-Aliaga, MJ (2007) Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin-secretion in primary cultured rat adipocytes. Mol Cell Endocrinol 268, 50–58.
26Navarro, V, Fernandez-Quintela, A, Churruca, I & Portillo, MP (2006) The fat-lowering effect of conjugated linoleic acid: a comparison between animal and human studies. J Physiol Biochem 62, 137–148.
27Tricon, S & Yaqoob, P (2006) Conjugated linoleic acid and human health: a critical evaluation of the evidence. Curr Opin Nutr Metab Care 9, 105–110.
28Close, RN, Schoeller, DA, Watras, AC & Nora, EH (2007) Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep. Am J Clin Nutr 86, 797–804.
29Whigham, LD, Watras, AC & Schoeller, DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 85, 1203–1211.
30Laude, AJ & Prior, IA (2004) Plasma membrane microdomains: organization, function and trafficking. Mol Membr Biol 21, 193–205.
31Hancock, JF (2006) Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 7, 456–462.
32Anderson, RGW (1998) The caveolae membrane system. Annu Rev Biochem 67, 199–225.
33Simons, K & Ikonen, E (1997) Functional rafts in cell membranes. Nature 387, 569–572.
34Prior, IA, Muncke, C, Parton, RG & Hancock, JF (2003) Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 160, 165–170.
35Stillwell, W & Wassall, SR (2003) Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 126, 1–27.
36Fan, YY, Ly, LH, Barhoumi, R, McMurray, DN & Chapkin, RS (2004) Dietary docosahexaenoic acid suppresses T-cell protein kinase C-theta lipid raft recruitment and interleukin-2 production. J Immunol 173, 6151–6160.
37Ma, DW, Seo, J, Davidson, LA, Callaway, ES, Fan, YY, Lupton, JR & Chapkin, RS (2004) n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 18, 1040–1042.
38Zeyda, M, Säemann, MD, Stuhlmeier, KM, Mascher, DG, Nowotny, PN, Zlabinger, GJ, Waldhäusl, W & Stulnig, TM (2005) Polyunsaturated block dendritic cell activation and function independently of NF-κB activation. J Biol Chem 280, 14293–14301.
39Geyeregger, R, Zeyda, M, Zlabinger, GJ, Waldhäusl, W & Stulnig, TM (2005) Polyunsaturated fatty acids interfere with formation of the immunological synapse. J Leuk Biol 77, 680–688.
40Stulnig, TM, Berger, M, Sigmund, T, Raederstorff, D, Stockinner, H & Waldhäusl, W (1998) Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol 143, 637–644.
41Stulnig, TM, Huber, J, Leitinger, N, Imre, E-M, Angelisová, P, Nowotny, P & Waldhäusl, W (2001) Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 276, 37335–37340.
42Fowler, KH, McMurray, DN, Fan, YY, Aukema, HM & Chapkin, RS (1993) Purified dietary n-3 polyunsaturated fatty acids alter diacylglycerol mass and molecular species composition in concanavalin A stimulated murine splenocytes. Biochim Biophys Acta 1210, 89–96.
43Switzer, KC, McMurray, DN, Morris, JS & Chapkin, RS (2003) Dietary n-3 polyunsaturated fatty acids selectively promote activation-induced cell death in T-lymphocytes. J Nutr 133, 496–503.
44Fan, YY, McMurray, DN, Ly, LH & Chapkin, RS (2003) Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr 133, 1913–1920.
45Switzer, KC, Fan, YY, Wang, N, McMurray, DM & Chapkin, RS (2004) Dietary n-3 polyunsaturated fatty acids promote activation-induced cell death in the Th1-polarized murine CD4+T-cells. J Lipid Res 45, 1482–1492.
46Leitenberg, D, Balamuth, F & Bottomly, K (2001) Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation. Sem Immunol 13, 129–138.
47Gaus, K, Chklovskaia, E, Fazekas de St Groth, B, Jessup, W & Harder, T (2005) Condensation of the plasma membrane at the site of T lymphocyte activation. J Cell Biol 171, 121–131.
48Harder, T, Rentero, C, Zech, T & Gaus, K (2007) Plasma membrane segregation during T cell activation: probing the order of domains. Curr Opin Immunol 19, 470–475.
49Shaikh, SR & Edidin, M (2007) Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules. J Lipid Res 48, 127–138.
50Huot, PS & Ma, WL (2007) .
51Yin, JJ, Kramer, JK, Yurawecz, MP, Eynard, AR, Mossoba, MM & Yu, L (2006) Effects of conjugated linoleic acid (CLA) isomers on oxygen diffusion-concentration products in liposomes and phospholipids solutions. J Agric Food Chem 54, 7287–7293.
52Huster, D, Arnold, K & Gawrisch, K (1998) Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 37, 17299–17308.
53Mitchell, DC & Litman, BJ (1998) Effect of cholesterol on molecular order and dynamics in highly polyunsaturated phospholipid bilayers. Biophys J 75, 896–908.
54Pasenkiewicz-Gierula, M, Subczynski, WK & Kusumi, A (1991) Influence of phospholipid unsaturation on the cholesterol distribution in membranes. Biochimie 73, 1311–1316.
55Niu, SL & Litman, BJ (2002) Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition. Biophys J 83, 3408–3415.
56Zerouga, M, Jenski, LJ & Stillwell, W (1995) Comparison of phosphatidylcholines containing one or two docosahexaenoic acyl chains on properties of phospholipid monolayers and bilayers. Biochim Biophys Acta 1236, 266–272.
57Kariel, N, Davidson, E & Keough, KM (1991) Cholesterol does not remove the gel-liquid crystalline phase transition of phosphatidylcholines containing two polyenoic acyl chains. Biochim Biophys Acta 1062, 70–76.
58Needham, D & Nunn, RS (1990) Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys J 58, 997–1009.
59Mitchell, DC & Litman, BJ (1998) Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. Biophys J 74, 879–891.
60Brzustowicz, MR, Cherezov, V, Caffrey, M, Stillwell, W & Wassall, SR (2002) Molecular organization of cholesterol in polyunsaturated membranes: microdomain formation. Biophys J 82, 285–298.
61Brzustowicz, MR, Cherezov, V, Zerouga, M, Caffrey, M, Stillwell, W & Wassall, SR (2002) Controlling membrane cholesterol content. A role for polyunsaturated (docosahexaenoate) phospholipids. Biochemistry 41, 12509–12519.
62Pasenkiewicz-Gierula, M, Subczynski, WK & Kusumi, A (1990) Rotational diffusion of a steroid molecule in phosphatidylcholine-cholesterol membranes: fluid-phase microimmiscibility in unsaturated phosphatidylcholine-cholesterol membranes. Biochemistry 29, 4059–4069.
63Huang, J & Feigenson, GW (1999) A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys J 76, 2142–2157.
64Shaikh, SR, Cherezov, V, Caffrey, M, Stillwell, W & Wassall, SR (2003) Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for microdomain/raft formation? Biochemistry 42, 12028–12037.
65Danbara, N, Yuri, T, Tsujita-Kyutoku, M, Sato, M, Senzaki, H, Takada, H, Hada, T, Miyazawa, T, Okazaki, K & Tsubura, A (2004) Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of Colo 201 human colon cancer cells. Nutr Cancer 50, 71–79.
66Kimura, Y & Sumiyoshi, M (2005) Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing. Cancer Sci 96, 441–450.
67Yonezawa, Y, Tsuzuki, T, Eitsuka, T, et al. (2005) Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II. Arch Biochem Biophys 435, 197–206.
68Tsuzuki, T, Tanaka, K, Kuwahara, S & Miyazawa, T (2005) Synthesis of the conjugated trienes 5E,7E,9E,14Z,17Z-eiocospentaenoic acid and 5Z,7E,9E,14Z,17Z-eiocsapentaenoic acid and their induction of apoptosis in DLD-1 colorectal adenocarcinoma cells. Lipids 40, 147–154.
69Tsuzuki, T, Kambe, T, Shibata, A, Kawakami, Y, Nakagawa, K & Miyazawa, T (2007) Conjugated EPA activates mutant p53 via lipid peroxidation and induces p53-dependent apoptosis in DLD-1 colorectal adenocarcinoma human cells. Biochim Biophys Acta 1771, 20–30.
70Tsuzuki, T, Kawakami, Y, Nakagawa, K & Miyazawa, T (2006) Conjugated docosahexaenoic acid inhibits lipid accumulation in rats. J Nutr Biochem 17, 518–524.
71Tsuzuki, T, Shibata, A, Kawakami, Y, Nakagaya, K & Miyazawa, T (2007) Anti-angiogenic effects of conjugated docosahexaenoic acid in vitro and in vivo. Biosci Biotechnol Biochem 71, 1902–1910.